[go: up one dir, main page]

DE602005007734D1 - Verfahren zur herstellung von telmisartan - Google Patents

Verfahren zur herstellung von telmisartan

Info

Publication number
DE602005007734D1
DE602005007734D1 DE602005007734T DE602005007734T DE602005007734D1 DE 602005007734 D1 DE602005007734 D1 DE 602005007734D1 DE 602005007734 T DE602005007734 T DE 602005007734T DE 602005007734 T DE602005007734 T DE 602005007734T DE 602005007734 D1 DE602005007734 D1 DE 602005007734D1
Authority
DE
Germany
Prior art keywords
telmisartan
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005007734T
Other languages
English (en)
Inventor
Rajendra Narayanrao Kankan
Dharmaraj Ramachandra Rao
Pathi L Srinivas
Puppala Ravikumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of DE602005007734D1 publication Critical patent/DE602005007734D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602005007734T 2004-05-11 2005-05-10 Verfahren zur herstellung von telmisartan Expired - Lifetime DE602005007734D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0410471A GB2414019A (en) 2004-05-11 2004-05-11 One-step preparation of telmisartan by condensation and hydrolysis
PCT/GB2005/001799 WO2005108375A1 (en) 2004-05-11 2005-05-10 Process for the preparation of telmisartan

Publications (1)

Publication Number Publication Date
DE602005007734D1 true DE602005007734D1 (de) 2008-08-07

Family

ID=32526813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005007734T Expired - Lifetime DE602005007734D1 (de) 2004-05-11 2005-05-10 Verfahren zur herstellung von telmisartan

Country Status (15)

Country Link
US (1) US8691999B2 (de)
EP (1) EP1748990B1 (de)
JP (1) JP5160219B2 (de)
KR (1) KR101183034B1 (de)
AR (1) AR048954A1 (de)
AT (1) ATE399157T1 (de)
AU (1) AU2005240836B2 (de)
CA (1) CA2566431C (de)
DE (1) DE602005007734D1 (de)
ES (1) ES2308494T3 (de)
GB (1) GB2414019A (de)
NZ (1) NZ551255A (de)
PT (1) PT1748990E (de)
WO (1) WO2005108375A1 (de)
ZA (1) ZA200609290B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943781B2 (en) 2004-10-18 2011-05-17 Dr. Reddy's Laboratories Limited Process for preparing telmisartan
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
CN101172968B (zh) * 2006-11-01 2010-05-12 浙江天宇药业有限公司 2-正丙基-4甲基-6-(甲基苯并咪唑-2-基)苯并咪唑盐及其制备方法
CZ302272B6 (cs) 2007-07-09 2011-01-19 Zentiva, A. S. Zpusob výroby 4´-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-karboxylové kyseliny (telmisartanu)
WO2009123483A1 (en) 2008-03-31 2009-10-08 Zaklady Farmaceutyczne Polpharma Sa Process for preparation of telmisartan
EP2123648A1 (de) 2008-05-20 2009-11-25 Chemo Ibérica, S.A. Verfahren zur Herstellung von Telmisartan
WO2010018441A2 (en) * 2008-08-11 2010-02-18 Cadila Pharmaceuticals Ltd. An improved process for the preparation of substantially pure telmisartan
KR100893652B1 (ko) 2008-11-10 2009-04-17 주식회사종근당 신규한 텔미사르탄 아연염 및 그의 제조방법
EP2443094B1 (de) * 2009-06-19 2013-03-20 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur herstellung von telmisartan
JP5711888B2 (ja) * 2010-01-26 2015-05-07 株式会社Ｄｎｐファインケミカル宇都宮 テルミサルタンアルキルエステルの製造法
KR20110094751A (ko) * 2010-02-17 2011-08-24 동화약품주식회사 텔미사탄의 개선된 제조방법
EA025946B1 (ru) 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
CN102219746B (zh) * 2011-04-07 2014-02-26 威海迪素制药有限公司 替米沙坦杂质b的制备方法
CN102212034B (zh) * 2011-04-14 2014-02-26 威海迪素制药有限公司 替米沙坦杂质b的制备方法
CN102267949A (zh) * 2011-06-14 2011-12-07 张长利 替米沙坦制备新工艺
KR101607661B1 (ko) * 2013-12-24 2016-03-31 주식회사 파마코스텍 텔미사르탄의 신규 제조 방법
JP6284861B2 (ja) * 2014-09-03 2018-02-28 株式会社トクヤマ テルミサルタンの製造方法
CN106008356B (zh) * 2016-06-07 2023-02-28 浙江华海药业股份有限公司 一种替米沙坦的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
DE4408497A1 (de) * 1994-03-14 1995-09-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US6416487B1 (en) 1997-07-30 2002-07-09 Renal Tech International Llc Method of removing beta-2 microglobulin from blood
AU1042199A (en) 1998-11-06 2000-05-29 Boehringer Ingelheim International Gmbh Antihypertensive medicaments containing lacidipine and telmisartan
US6358986B1 (en) * 1999-01-19 2002-03-19 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
DE19901921C2 (de) * 1999-01-19 2001-01-04 Boehringer Ingelheim Pharma Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels
CN1182122C (zh) * 2001-07-30 2004-12-29 中国科学院上海药物研究所 替米沙坦的合成新路线
CN1204124C (zh) 2001-10-15 2005-06-01 中国科学院上海药物研究所 替米沙坦的一种制备路线
DE10201725A1 (de) * 2002-01-18 2003-08-14 Boehringer Ingelheim Pharma Verfahren zur Herstellung und Reinigung von 1,7'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazol
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan

Also Published As

Publication number Publication date
GB2414019A (en) 2005-11-16
KR20070012546A (ko) 2007-01-25
JP5160219B2 (ja) 2013-03-13
US8691999B2 (en) 2014-04-08
EP1748990B1 (de) 2008-06-25
WO2005108375A1 (en) 2005-11-17
ZA200609290B (en) 2008-05-28
AU2005240836B2 (en) 2010-09-23
KR101183034B1 (ko) 2012-09-17
AR048954A1 (es) 2006-06-14
CA2566431A1 (en) 2005-11-17
NZ551255A (en) 2010-03-26
ATE399157T1 (de) 2008-07-15
JP2007537222A (ja) 2007-12-20
US20080015359A1 (en) 2008-01-17
AU2005240836A1 (en) 2005-11-17
ES2308494T3 (es) 2008-12-01
GB0410471D0 (en) 2004-06-16
CA2566431C (en) 2013-04-09
PT1748990E (pt) 2008-09-10
EP1748990A1 (de) 2007-02-07

Similar Documents

Publication Publication Date Title
DE602005009866D1 (de) Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden
DE602005018601D1 (de) Verfahren zur herstellung von 2-aminothiazol-5-aro
EP1934354A4 (de) Verfahren zur herstellung von hybridsaat
DE502005002059D1 (de) Verfahren zur herstellung von polyetheralkoholen
DE502006008840D1 (de) Verfahren zur Herstellung von Isocyanaten
DE602004010234D1 (de) Verfahren zur herstellung von 4-aminodiphenylamin
DE502007003700D1 (de) Verfahren zur Herstellung von Glycerin
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE502006004698D1 (de) Verfahren zur Herstellung von sublithographischen Strukturen
DE502006000138D1 (de) Verfahren zur Herstellung von Triorganosiloxygruppen aufweisenden Organopolysiloxanen
DE602005007734D1 (de) Verfahren zur herstellung von telmisartan
DE502006006498D1 (de) Verfahren zur Herstellung von Organopolysiloxanen
ATA8002004A (de) Verfahren zur herstellung von 2-butanol
DE602004005137D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE502005005085D1 (de) Verfahren zur Herstellung von Iminooxadiazindiongruppen aufweisenden Polyisocyanaten
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
DE602007003135D1 (de) Verfahren zur Herstellung von Xylylenediamin
DE602005017099D1 (de) Verfahren zur Herstellung von amorphem Cefuroximaxetil
DE602006008306D1 (de) Verfahren zur herstellung von l-threonin
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
EP1914220A4 (de) Verfahren zur herstellung von 2-hydroxyestern
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
DE602005024566D1 (de) Verfahren zur herstellung von 2-amino-5-iodobenzoesäure
DE502007000222D1 (de) Verfahren zur Herstellung von Methylchlorsilanen
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition